Published online Nov 27, 2026. doi: 10.4254/wjh.125467
Revised: August 5, 2026
Accepted: October 8, 2026
Published online: November 27, 2026
Processing time: 135 Days and 11.1 Hours
Deaths unrelated to hepatocellular carcinoma (HCC) may be clinically relevant when patients survive long enough for age, chronic liver disease, cardiovascular disease, infection, and other conditions to influence mortality. Standard survival analyses may misrepresent this risk as HCC death precludes subsequent non-HCC death.
To estimate the cumulative incidence of non-HCC death and identify how its adjusted associations change during follow-up in a population-based HCC cohort.
We analyzed 31274 adults with first primary HCC diagnosed during 2010-2015 in the Surveillance, Epidemiology, and End Results 17-registry database. Non-HCC death was the event of interest and HCC death was the competing event. Cu
During a reverse Kaplan-Meier median follow-up of 97 months [95% confidence interval (CI): 96-99], 22290 patients died from HCC and 3880 died from non-HCC causes; non-HCC deaths comprised 14.8% of all deaths. The cumulative incidence of non-HCC death was 6.2% (95%CI: 6.0%-6.5%) at 12 months, 9.8% (95%CI: 9.4%-10.1%) at 36 months, and 11.2% (95%CI: 10.8%-11.5%) at 60 months. The proportional subdistribution hazards assumption was rejected (global Wald χ2 = 836.6, 21 df, P < 0.001). For age 75 years or older vs 18-49 years, adjusted subdistribution hazard ratios increased from 1.33 (95%CI: 1.15-1.53) at 12 months to 1.74 (95%CI: 1.40-2.17) at 60 months. Advanced stage and larger tumors showed lower subdistribution hazards but not consistently lower cause-specific hazards, a pattern compatible with dominant competing HCC mortality. Associations with recorded surgery and chemotherapy crossed the null over time and cannot be interpreted as treatment effects.
Non-HCC death accounted for approximately one in seven deaths after HCC diagnosis. Its associations were time dependent, and a single constant subdistribution hazard ratio obscured clinically important changes during follow-up. The findings support competing-risk assessment and continued management of non-cancer health risks, while treatment comparisons remain vulnerable to selection and survivor bias.
Core Tip: Among 31274 patients with hepatocellular carcinoma (HCC), 3880 non-HCC deaths represented 14.8% of all deaths. The proportional subdistribution hazards assumption was strongly violated; therefore, adjusted subdistribution hazard ratios were estimated at 12 months, 36 months, and 60 months rather than summarized by one constant value. Older age remained associated with higher non-HCC mortality, whereas apparent associations for tumor burden and treatment reflected competing HCC death, patient selection, and changing risk sets. These registry associations should not be read as causal treatment effects.